ENTRY       D00674                      Drug
NAME        Naratriptan hydrochloride (JAN/USP);
            Amerge (TN)
PRODUCT
  GENERIC   NARATRIPTAN (A-S Medication Solutions)
            NARATRIPTAN (Bionpharma)
            NARATRIPTAN (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            NARATRIPTAN (Hikma Pharmaceuticals USA)
FORMULA     C17H25N3O2S. HCl
EXACT_MASS  371.1434
MOL_WEIGHT  371.9252
CLASS       Neuropsychiatric agent
             DG01483  5-HT1A-receptor agonist
            Analgesic
             DG01484  5-HT1B-receptor agonist
             DG01485  5-HT1D-receptor agonist
             DG01518  5-HT1B/1D-receptor agonist
             DG01943  Triptan
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01642  CYP2C9 substrate
             DG01644  CYP2D6 substrate
             DG02855  CYP2E1 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02925  CYP3A5 substrate
REMARK      Therapeutic category: 2160
            ATC code: N02CC02
            Chemical structure group: DG00837
            Product (DG00837): D00674<JP/US>
EFFICACY    Antimigraine, Vasoconstrictor, Serotonin receptor agonist
COMMENT     Sumatriptan derivative
TARGET      HTR1B [HSA:3351] [KO:K04153]
            HTR1D [HSA:3352] [KO:K04153]
  PATHWAY   hsa04080(3351+3352)  Neuroactive ligand-receptor interaction
            hsa04726(3351+3352)  Serotonergic synapse
METABOLISM  Enzyme: CYP1A2 [HSA:1544], CYP2C9 [HSA:1559], CYP2D6 [HSA:1565], CYP2E1 [HSA:1571], CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]
INTERACTION  
STR_MAP     map07048  Antimigraines
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N02 ANALGESICS
               N02C ANTIMIGRAINE PREPARATIONS
                N02CC Selective serotonin (5HT1) agonists
                 N02CC02 Naratriptan
                  D00674  Naratriptan hydrochloride (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antimigraine Agents
              Serotonin (5-HT) Receptor Agonists
               Naratriptan
                D00674  Naratriptan hydrochloride (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               216  Vasoconstrictors
                2160  Vasoconstrictors
                 D00674  Naratriptan hydrochloride (JAN/USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01483  5-HT1A-receptor agonist
               DG00837  Naratriptan
                D00674  Naratriptan hydrochloride
             Analgesic
              DG01484  5-HT1B-receptor agonist
               DG00837  Naratriptan
                D00674  Naratriptan hydrochloride
              DG01485  5-HT1D-receptor agonist
               DG00837  Naratriptan
                D00674  Naratriptan hydrochloride
              DG01518  5-HT1B/1D-receptor agonist
               DG00837  Naratriptan
                D00674  Naratriptan hydrochloride
              DG01943  Triptan
               DG00837  Naratriptan
                D00674  Naratriptan hydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00837  Naratriptan
                D00674  Naratriptan hydrochloride
              DG01642  CYP2C9 substrate
               DG00837  Naratriptan
                D00674  Naratriptan hydrochloride
              DG01644  CYP2D6 substrate
               DG00837  Naratriptan
                D00674  Naratriptan hydrochloride
              DG02855  CYP2E1 substrate
               DG00837  Naratriptan
                D00674  Naratriptan hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00837  Naratriptan
                 D00674  Naratriptan hydrochloride
              DG02925  CYP3A5 substrate
               DG00837  Naratriptan
                D00674  Naratriptan hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Serotonin
                HTR1B
                 D00674  Naratriptan hydrochloride (JAN/USP) &lt;JP/US&gt;
                HTR1D
                 D00674  Naratriptan hydrochloride (JAN/USP) &lt;JP/US&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00674
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00674
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01483  5-HT1A-receptor agonist
               DG00837  Naratriptan
             Analgesic
              DG01484  5-HT1B-receptor agonist
               DG00837  Naratriptan
              DG01485  5-HT1D-receptor agonist
               DG00837  Naratriptan
              DG01518  5-HT1B/1D-receptor agonist
               DG00837  Naratriptan
              DG01943  Triptan
               DG00837  Naratriptan
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00837  Naratriptan
              DG01642  CYP2C9 substrate
               DG00837  Naratriptan
              DG01644  CYP2D6 substrate
               DG00837  Naratriptan
              DG02855  CYP2E1 substrate
               DG00837  Naratriptan
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00837  Naratriptan
              DG02925  CYP3A5 substrate
               DG00837  Naratriptan
DBLINKS     CAS: 143388-64-1
            PubChem: 7847740
            ChEBI: 7479
            LigandBox: D00674
ATOM        24
            1   C8y C    33.6700  -19.1800
            2   C8y C    35.0000  -18.6900
            3   C8y C    33.6700  -20.5800
            4   C8x C    32.4100  -18.4800
            5   C8x C    35.8400  -19.8800
            6   N4x N    35.0000  -21.0000
            7   C8x C    32.4100  -21.2800
            8   C8y C    31.2200  -19.1800
            9   C8x C    31.2200  -20.5800
            10  C1b C    30.0300  -18.4800
            11  C1b C    28.8400  -19.1800
            12  S4a S    27.5800  -18.4800
            13  N1b N    26.3900  -19.1800
            14  O3c O    28.8400  -17.7800
            15  O3c O    26.3900  -17.7800
            16  C1a C    25.2000  -18.4800
            17  C1y C    35.0000  -17.2900
            18  C1x C    36.1900  -16.5900
            19  C1x C    36.1900  -15.1900
            20  N1y N    35.0000  -14.4900
            21  C1x C    33.8100  -15.1900
            22  C1x C    33.8100  -16.5900
            23  C1a C    35.0000  -13.0900
            24  X   Cl   38.9900  -19.8800
BOND        25
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     3   6 1
            6     3   7 1
            7     4   8 2
            8     7   9 2
            9     8  10 1
            10   10  11 1
            11   11  12 1
            12   12  13 1
            13   12  14 2
            14   12  15 2
            15   13  16 1
            16    5   6 1
            17    8   9 1
            18    2  17 1
            19   17  18 1
            20   18  19 1
            21   19  20 1
            22   20  21 1
            23   21  22 1
            24   17  22 1
            25   20  23 1
///
